Another biotech to add to our basket. I'm bullish on gild after a weak few months, 7x earnings excluding r&d with the fortress HIV providing most of cash flow.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.